Studies on the central action of L-threo-3,4-dihydroxyphenyl-serine (L-threo-DOPS) in FLA-63-treated mice

This publication has 17 references indexed in Scilit:

• Reversal of the reserpine-induced ptosis by l-threo-3,4-dihydroxy-phenylserine (l-threo-DOPS), a (?)-norepinephrine precursor, and its potentiation by imipramine or nialamide
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1986
• Increased brain concentration of homovanillic acid in rats treated with threo-3,4-dihydroxyphenylserine
  Journal of Pharmacy and Pharmacology, 1982
• Effects of amino acid precursors on catecholamine synthesis in the brain
  Progress in Neuro-Psychopharmacology, 1981
• The importance of serotonergic mechanisms for the induction of hyperactivity by amphetamine and its antagonism by intra-accumbens (3,4-dihydroxy-phenylamino)-2-imidazoline (DPI)
  Neuropharmacology, 1979
• Characterisation of the mechanisms for hyperactivity induction from the nucleus accumbens by phenylethylamine derivatives
  Psychopharmacology, 1976
• Antagonism by DL-threo-DOPS of the suppression of a conditioned avoidance response induced by a dopamine-?-Hydroxylase inhibitor
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1973
• Dopamine, noradrenaline and 5-hydroxy-tryptamine in relation to motor activity, fighting and mounting behaviour: I. l-DOPA and dl-threo-dihydroxyphenylserine in combination with Ro 4-4602, pargyline and reserpine
  Neuropharmacology, 1973
• L-dopa and imipramine: Biochemical and behavioral interaction
  European Journal of Pharmacology, 1972
• Histochemical studies on the effect of (+)-amphetamine, drugs of the imipramine group and tryptamine on central catecholamine and 5-hydroxytryptamine neurons after intraventricular injection of catecholamines and 5-hydroxytryptamine
  European Journal of Pharmacology, 1968
• Zur Biochemie des Parkinson-Syndroms des Menschen
  Klinische Wochenschrift, 1963